Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Many studies assessed the impact of marine omega-3 fatty acids on glycemic homeostasis and lipid profiles in patients with type 2 diabetes (T2DM), but reported controversial results. Our goal was to systematically evaluate the effects of omega-3 on glucose control and lipid levels. METHODS: Medline, Pubmed, Cochrane Library, Embase, the National Research Register, and SIGLE were searched to identify eligible randomized clinical trials (RCTs). Extracted data from RCTs were analyzed using STATA 11.0 statistical software with fixed or random effects model. Effect sizes were presented as weighted mean differences (WMD) with 95% confidence intervals (95% CI). Heterogeneity was assessed using the Chi-square test with significance level set at p < 0.1. RESULTS: 20 RCT trials were included into this meta-analysis. Among patients with omega-3 supplementation, triglyceride (TG) levels were significantly decreased by 0.24 mmol/L. No marked change in total cholesterol (TC), HbA1c, fasting plasma glucose, postprandial plasma glucose, BMI or body weight was observed. High ratio of EPA/DHA contributed to a greater decreasing tendency in plasma insulin, HbAc1, TC, TG, and BMI measures, although no statistical significance was identified (except TG). FPG levels were increased by 0.42 mmol/L in Asians. No evidence of publication bias was observed in this meta-analysis. CONCLUSIONS: The ratio of EPA/DHA and early intervention with omega 3 fatty acids may affect their effects on glucose control and lipid levels, which may serve as a dietary reference for clinicians or nutritionists who manage diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“meta-analyses of older studies and more recent publications have shown that 4 g/d Downloaded from http://ahajournals.org by on September 1, 2023”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Omega-3 fatty acid supplements have not reduced CVD events or mortality in randomized trials but may have utility in people who require triglyceride reduction (304,306).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [306]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Evidence does not conclusively support recommending omega-3 (EPA and DHA) supplements for all people with diabetes for the prevention or treatment of cardiovascular events.”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [306]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · cited 1×
“We adopted the criterion system developed by Jadad and Schulz [35,36], which had a possible range from 0 to 5 with 2 as a cutoff for the selection of high-quality studies.”
MethodDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
Prevention and management of type 2 diabetes: dietary components and nutritional strategies
Ley, S. H., Hamdy, O., Mohan, V., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60613-9 · Cited by 1,301 · cited 1×
“That adherence to a healthy diet can improve glycemic control has been getting more and more attention of clinicians and nutritionists [4,5].”
BackgroundKromann, N., & Green, A. (1980) · PubMed · Cited by 851
The composition of the Eskimo food in north western Greenland.
Bang, H. O., Dyerberg, J., & Sinclair, H. M. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.12.2657 · Cited by 807 · cited 1×
“attributed such benefits of fish consumption to its main components, omega 3 fatty acids (in particular for eicosapentaenoic acid (C20:5n-3, EPA) and docosahexaenoic acid (C22:6n-3,DHA))—a group of homologue fatty acids belonging to polyunsaturated fatty acids (PUFAs) [7].”
Background
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
Brown, T. J., Brainard, J., Song, F., Wang, X., Abdelhamid, A., & Hooper, L. (2019) · BMJ · doi:10.1136/bmj.l4697 · Cited by 313
The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging
Bruins, M. J., Van Dael, P., & Eggersdorfer, M. (2019) · Nutrients · doi:10.3390/nu11010085 · Cited by 223
“These findings will be helpful for clinicians and nutritionists who manage patients with diabetes to provide dietary guidance [141].”
BackgroundInfluentialBanaszak, M., Dobrzyńska, M., Kawka, A., Górna, I., Woźniak, D., Przysławski, J., & Drzymała-Czyż, S. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.06.053 · Cited by 161
“…patients showed that omega-3 supplementation, and in particular, a high EPA/DHA ratio (EPA/DHA > 1.5) contributed to a reduction in plasma insulin, glycated haemoglobin (HbA1c), total cholesterol (TC), TG and BMI), however, no statistical signi fi cance was found except for TG ( p < 0.001) [65].”
InfluentialO’Mahoney, L. L., Matu, J., Price, O. J., Birch, K. M., Ajjan, R. A., Farrar, D., Tapp, R., West, D. J., Deighton, K., & Campbell, M. D. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0740-x · Cited by 157
“Significant heterogeneity of effect between primary trials has been observed [19–21], which is likely to have arisen, at least in part, as a result of variable supplementation dosage and duration, either of which may modify the effects of n-3PUFAs on cardio-metabolic biomarkers [22].”
InfluentialMohan, D., Mente, A., Dehghan, M., Rangarajan, S., O’Donnell, M., Hu, W., Dagenais, G., Wielgosz, A., Lear, S., Wei, L., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.0036 · Cited by 147
Pellonperä, O., Mokkala, K., Houttu, N., Vahlberg, T., Koivuniemi, E., Tertti, K., Rönnemaa, T., & Laitinen, K. (2019) · Diabetes Care · doi:10.2337/dc18-2591 · Cited by 145
“ratio of EPA/DHA could be beneficial in termsof glucose control (25).”
BackgroundDama, A., Shpati, K., Daliu, P., Dümür, Ş., Gorica, E., & Santini, A. (2024) · Nutrients · doi:10.3390/nu16040507 · Cited by 165
“Pharmacological supplements containing DHA + EPA have shown effectiveness in conditions with elevated triglycerides [67,68].”
BackgroundPoreba, M., Mostowik, M., Siniarski, A., Golebiowska-Wiatrak, R., Malinowski, K. P., Haberka, M., Konduracka, E., Nessler, J., Undas, A., & Gajos, G. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0523-9 · Cited by 98
“[26] demonstrated that in DM2 n-3 PUFAs did not change HbA1c, fasting insulin, FPG, or postprandial glucose levels, which is in accordance with our results.”
ResultAn Improvement of Cardiovascular Risk Factors by Omega-3 Polyunsaturated Fatty Acids
Yanai, H., Masui, Y., Katsuyama, H., Adachi, H., Kawaguchi, A., Hakoshima, M., Waragai, Y., Harigae, T., & Sako, A. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3362w · Cited by 107
“All RCTs that investigated effects of omega-3 PUFA supplements on insulin resistance in women with polycystic ovary syndrome (PCOS) were included.”
MethodInfluentialMesinovic, J., Fyfe, J. J., Talevski, J., Wheeler, M. J., Leung, G. K. W., George, E. S., Hunegnaw, M. T., Glavas, C., Jansons, P., Daly, R. M., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0112 · Cited by 114
“Other meta-analyses have shown no effect of omega-3 FA supplementation on glycemic indices [110,111].”
BackgroundPromising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
Rizzo, G., Baroni, L., & Lombardo, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031683 · Cited by 106
Gene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate
Ortega, Á., Berná, G., Rojas, A., Martín, F., & Soria, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061188 · Cited by 96
“In overweight/obese patients with impaired fasting glucose or impaired glucose tolerance, n-3 PUFAs reduced glycemia and fasting plasma insulin [186], while in T2DM patients with omega-3 supplementation, a high ratio of eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) contributed to a greater decreasing tendency i…”
BackgroundThe emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders
Reimers, A., & Ljung, H. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319858901 · Cited by 75
O’Neill, C. M., & Minihane, A. M. (2016) · Proceedings of The Nutrition Society · doi:10.1017/s0029665116000732 · Cited by 82
Jovanovski, E., Li, D., Ho, H. V. T., Djedovic, V., Marques, A. D. C. R., Shishtar, E., Mejía, S. B., Sievenpiper, J. L., de Souza, R. J., Duvnjak, L. S., et al. (2017) · Medicine · doi:10.1097/md.0000000000006531 · Cited by 88
Zheng, J., Lin, M., Fang, L., Yu, Y., Yuan, L., Jin, Y., Feng, J., Wang, L., Yang, H., Chen, W., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600230 · Cited by 69
Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review
Minari, T. P., Tácito, L. H. B., Yugar, L. B. T., Ferreira‐Melo, S. E., Manzano, C. F., Pires, A. C., Moreno, H., Vilela-Martin, J. F., Cosenso‐Martin, L. N., & Yugar‐Toledo, J. C. (2023) · Nutrients · doi:10.3390/nu15245096 · Cited by 104
“Another research showed that vitamin D supplementation with 1 g of omega-3 in patients with T2DM also did not result in a lower incidence and fewer predictors of major adverse cardiovascular events [89].”
BackgroundGonzález‐Sarrías, A., Combet, E., Pinto, P., Mena, P. R., Dall’Asta, M., Garcia‐Aloy, M., Rodriguez‐Mateos, A., Gibney, E. R., Dumont, J., Massaro, M., et al. (2017) · Nutrients · doi:10.3390/nu9070746 · Cited by 69
“It has been reported that Asians showed a more marked decrease in the levels of TAGs in response to$-3 fatty acids supplementation as compared to subjects within a USA/European group but, no significant differences were found for total cholesterol or BMI [157].”
Complementary and Alternative Medicine for Diabetes
Grossman, L. D., Roscoe, R. S., & Shack, A. R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.023 · Cited by 72
Associations between Nutrients and Foot Ulceration in Diabetes: A Systematic Review
Bechara, N., Gunton, J. E., Flood, V. M., Hng, T., & McGloin, C. (2021) · Nutrients · doi:10.3390/nu13082576 · Cited by 73
“We note lack of effect of omega-3 PUFA on HbA1c or markers of insulin resistance in people with type 2 diabetes reported in a Cochrane review [34] and in a more recent meta-analysis in 2015 [35].”
BackgroundKhalili, L., Valdés‐Ramos, R., & Harbige, L. S. (2021) · Metabolites · doi:10.3390/metabo11110742 · Cited by 68
Chang, J. P., Tseng, P., Zeng, B., Chang, C., Su, H., Chou, P., & Su, K. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.003 · Cited by 75
Wang, F., Wang, Y., Zhu, Y., Liu, X., Xia, H., Yang, X., & Sun, G. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1352-4 · Cited by 67
“In addition, the majority of randomized clinical trials support the triglyceride (TG)-lowering effect of fish oil supplementation in type 2 diabetic patients [14], but the effects on glycemic control are still inconclusive: Fasting blood glucose was either deteriorated [15–18] or unchanged [19–24].”
Gao, C., Liu, Y., Gan, Y., Bao, W., Peng, X., Xing, Q., Gao, H., Lai, J., Liu, L., Wang, Z., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01214-w · Cited by 60
“For instance, a meta-analysis [21] reported that fasting plasma glucose level in type 2 diabetic Asians was increased by 0.”
BackgroundInfluentialCardiovascular Diseases, Depression Disorders and Potential Effects of Omega-3 Fatty Acids
Trebatická, J., Dukát, A., Ďuračková, Z., & Muchová, J. (2017) · Physiological Research · doi:10.33549/physiolres.933430 · Cited by 57
Talebi, S., Bagherniya, M., Atkin, S. L., Askari, G., Orafai, H. M., & Sahebkar, A. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01250-6 · Cited by 61
Chen, C., Yang, Y., Yu, X., Hu, S., & Shao, S. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12614 · Cited by 60
Self-citationFADS Polymorphism, Omega-3 Fatty Acids and Diabetes Risk: A Systematic Review
Brayner, B., Kaur, G., Keske, M. A., & Livingstone, K. M. (2018) · Nutrients · doi:10.3390/nu10060758 · Cited by 56
“In addition, the longer the intervention lasted, the better its effect on glucose control and lipid levels [14].”
BackgroundArca, M., Borghi, C., Pontremoli, R., De Ferrari, G. M., Colivicchi, F., Desideri, G., & Temporelli, P. L. (2018) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.11.001 · Cited by 52
Prentice, K. J., Wendell, S. G., Liu, Y., Eversley, J. A., Salvatore, S. R., Mohan, H., Brandt, S. L., Adams, A. C., Wang, X. S., Wei, D., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.12.019 · Cited by 52
“Similar effects have also been observed in diabetic populations, including increases in fasting blood glucose (reviewed in (Chen et al., 2015; Friedberg et al., 1998)).”
BackgroundInfluentialChewcharat, A., Chewcharat, P., Rutirapong, A., & Papatheodorou, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228315 · Cited by 49
“However, our meta-analysis revealed no significant difference in HbA1C between treatment arms and control group which is congruent with the latest metaanalysis on the same topic for HbA1C by Chen et al [41].”
ResultPerilla Oil Supplementation Improves Hypertriglyceridemia and Gut Dysbiosis in Diabetic KKAy Mice
Wang, F., Zhu, H., Hu, M., Wang, J., Xia, H., Yang, X., Yang, L., & Sun, G. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800299 · Cited by 47
Chen, Y., Qiu, X. K., & Yang, J. P. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1804949 · Cited by 42
Effect of Fatty Acids on Glucose Metabolism and Type 2 Diabetes
Sivri, D., & Akdevelıoğlu, Y. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae165 · Cited by 55
Polycystic ovary syndrome and obesity: clinical aspects and nutritional management
FRIAS-TORAL, E., GARCIA-VELASQUEZ, E., de los ANGELES CARIGNANO, M., RODRIGUEZ-VEINTIMILLA, D., ALVARADO-AGUILERA, I., & BAUTISTA-LITARDO, N. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03349-6 · Cited by 40
Rangel-Huerta, Ó. D., & Gil, Á. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.05.015 · Cited by 43
Xu, B., Fu, J., Qiao, Y., Cao, J., Deehan, E. C., Li, Z., Jin, M., Wang, X., & Wang, Y. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa435 · Cited by 41
Itsiopoulos, C., Marx, W., Mayr, H. L., Tatucu-Babet, O. A., Dash, S. R., George, E. S., Trakman, G. L., Kelly, J. T., Thomas, C. J., & Brazionis, L. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.02.002 · Cited by 37
Food groups in dietary prevention of type 2 diabetes
Basiak-Rasała, A., Różańska, D., & Zatońska, K. (2019) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2019.0086 · Cited by 48
Polyphenols and ω-3 PUFAs: Beneficial Outcomes to Obesity and Its Related Metabolic Diseases
Siroma, T. K., Machate, D. J., Zorgetto-Pinheiro, V. A., Figueiredo, P. S., Marcelino, G., Hiane, P. A., Bogo, D., Pott, A., Pontes, E. R. J. C., Guimarães, R. D. C. A., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.781622 · Cited by 48
O’Neill, C. M., Cruz-Romero, M. C., Duffy, G., & Kerry, J. P. (2019) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2019.03.005 · Cited by 31
Epigenetic Effects of n-3 LCPUFAs: A Role in Pediatric Metabolic Syndrome
Amatruda, M., Ippolito, G., Vizzuso, S., Vizzari, G., Banderali, G., & Verduci, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092118 · Cited by 34
“In meta-analyses of randomized trials, biomarkers of glucose metabolism or insulin sensitivity in patients with or without diabetes seem not to be affected by n-3 PUFAs [38].”
BackgroundDietetic intervention in psoriatic arthritis: the DIETA trial
Leite, B. F., Morimoto, M. A., Gomes, C. M. F., Klemz, B. N. D. C., Genaro, P. D. S., Shivappa, N., Hébert, J. R., Damasceno, N. R. T., & Pinheiro, M. M. (2022) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-022-00243-6 · Cited by 29
“Several nonpharmacological strategies, including weight loss and antioxidant supplementation, have had beneficial effects on obesity [8, 9], dyslipidemia [10, 11], nonalcoholic fatty liver disease [10] and diabetes [11].”
BackgroundOnaolapo, A. Y., & Onaolapo, O. J. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666181031103930 · Cited by 33
Neto, J., Jantsch, J., de Oliveira, S., Braga, M. F., Castro, L. F. D. S., Diniz, B. F., Moreira, J. C. F., Giovenardi, M., Porawski, M., & Guedes, R. P. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003998 · Cited by 27
Khorshidi, M., Hazaveh, Z. S., Alimohammadi-kamalabadi, M., Jamshidi, S., Moghaddam, O. M., Olang, B., Hatefi, S., Hosseini, A., Jamilian, P., Zarezadeh, M., et al. (2023) · Nutrition Journal · doi:10.1186/s12937-022-00826-5 · Cited by 22
“revealed that omega-3 supplementation in patients suffered from type 2 diabetes resulted in a reduction in TG concentrations, while no marked effect was observed on TC levels [21].”
BackgroundMohammadi, M. R., Abbasalipourkabir, R., & Ziamajidi, N. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1789881 · Cited by 27
“There is growing evidence that fish oil supplementation has beneficial effects on many chronic diseases such as cardiovascular (AbuMweis et al. 2018), diabetes (Chen et al. 2015), asthma (Best et al. 2016), and NAFLD, as mentioned earlier (Chen et al. 2018).”
BackgroundMarushka, L., Hu, X., Batal, M., Sadik, T., Schwartz, H. M., Ing, A., Fediuk, K., Tikhonov, C., & Chan, H. M. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15030539 · Cited by 23
“Recent evidence suggests that consumption of fish, rich in long-chain n-3 FAs (eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA)) may help prevent T2D since their improved lipid profile, reduces insulin resistance and inflammation [25,26].”
BackgroundBrunetta, H. S., Camargo, C. D. Q., & Nunes, E. A. (2018) · Amino Acids · doi:10.1007/s00726-018-2658-8 · Cited by 22
The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease
Rivellese, A. A., Ciciola, P., Costabile, G., Vetrani, C., & Vitale, M. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00309-5 · Cited by 27
Yu, S., Xie, Q., Tan, W., Hu, M., Xu, G., Zhang, X., Xie, G., & Mao, L. (2023) · Food & Function · doi:10.1039/d2fo02686d · Cited by 23
Giuliani, M. E., Bigossi, G., Lai, G., Marcozzi, S., Brunetti, D., & Malavolta, M. (2024) · Marine Drugs · doi:10.3390/md22050210 · Cited by 23
“A meta-analysis including 20 randomised clinical trials on the effects of omega-3 in Type 2 diabetic patients revealed no significant changes for plasmatic glucose, glycosilated haemoglobin, body weight, or serum lipids, except for triglycerides, which were significantly decreased [177].”
MethodRijjal, D. A., Liu, Y., Lai, M., Song, Y., Danaei, Z., Wu, A., Mohan, H., Li, W., Schopfer, F. J., Dai, F. F., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102909 · Cited by 21
Hidayat, K., Zhu, W.-Z., Peng, S., Ren, J., Lu, M., Wang, H.-P., Xu, J., Zhou, H., Yu, L., & Qin, L. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521002452 · Cited by 22
AbuMweis, S. S., Omran, D. A., Al-Shami, I. K., & Jew, S. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102662 · Cited by 21
Wasserfurth, P., Nebl, J., Schuchardt, J. P., Müller, M., Boßlau, T. K., Krüger, K., & Hahn, A. (2020) · Nutrients · doi:10.3390/nu12072139 · Cited by 19
Kim, Y., Oh, Y. K., Lee, J., & Kim, E. Y. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01374-6 · Cited by 23
di Palumbo, A. S., McSwiney, F. T., Hone, M., McMorrow, A. M., Lynch, G. M., VITO, G. D., & Egan, B. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1897057 · Cited by 21
“…supplementation is effective at lowering concentrations of C-reactive protein (CRP) within persons with dyslipidemia and high baseline concentrations of CRP (Guo et al. 2019), and improving glycated hemoglobin (HbA1c) and blood lipid profile within persons with type 2 diabetes (Chen et al. 2015).”
BackgroundRajaram, S., Yip, E., Reghunathan, R., Mohan, S., & Sabaté, J. (2017) · Nutrients · doi:10.3390/nu9101162 · Cited by 16
Behdani, F., Roudbaraki, S. N., Saberi‐Karimian, M., Tayefi, M., Hebrani, P., Akhavanrezayat, A., Vahabi‐Amlashi, S., Ferns, G. A., & Ghayour‐Mobarhan, M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.028 · Cited by 16
Xie, J., Wang, Z., Wang, J., Feng, W. Q., Shan, T., Jing, S., Xiao, S., Li, W. L., Liu, N., & Liu, Y. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-02003-w · Cited by 15
Franck, M., de Toro‐Martín, J., Guénard, F., Rudkowska, I., Lemieux, S., Lamarche, B., Couture, P., & Vohl, M. (2019) · Lifestyle Genomics · doi:10.1159/000504022 · Cited by 17
Schüller, Á. K., Canata, D. A. M., Hackenhaar, F. S., Engers, V. K., Heemann, F. M., Putti, J. S., Salomon, T. B., & Benfato, M. S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.10.006 · Cited by 14
Dietary recommendations for persons with type 2 diabetes mellitus
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kleinridders, A., Kronsbein, P., Müssig, K., Nussbaumer, H., Pfeiffer, A. F. H., et al. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-5095 · Cited by 13
Jazayeri, S., Heshmati, J., Mokhtari, Z., Sepidarkish, M., Nameni, G., Potter, E., & Zaroudi, M. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102487 · Cited by 15
Wang, L., Huang, X., Sun, M., Zheng, T., Zheng, L., Lin, X., Ruan, J., & Lin, F. Y. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00262-w · Cited by 12
Jun, J. E., Jeong, I., Yu, J. M., Kim, S. R., Lee, I. K., Han, K. A., Choi, S. H., Kim, S., Park, H. K., Mok, J., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0265 · Cited by 20
Öz, M., Uçak, İ., & Nayik, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89779-2.00004-1 · Cited by 14
Meng, Y., Cai, W., Hua, T., Cheng, Q., Ai, D., Jiang, H., & Zhang, X. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13285 · Cited by 12
Machine Learning Metabolomics Profiling of Dietary Interventions from a Six-Week Randomised Trial
Kouraki, A., Nogal, A., Nocun, W., Louca, P., Vijay, A., Wong, K. E., Michelotti, G. A., Menni, C., & Valdes, A. M. (2024) · Metabolites · doi:10.3390/metabo14060311 · Cited by 11
“…essential nutrients for humans and are a promising nutritional therapeutic for many disorders, as demonstrated in a vast array of studies [5], showing efficacy on improving cardiometabolic and mental health outcomes [6,7] via the effects of these fatty acids on reducing systemic inflammation [8].”
BackgroundMuñoz, R. R. S., Quach, T. N., Neto, J. C. G., Xian, Y., Peña, P. A., Weier, S. A., Pellizzon, M., Kittana, H., Cody, L. A., Geis, A. L., et al. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000162 · Cited by 13
Omega-3 index and type 2 diabetes: Systematic review and meta-analysis
Ma, M., Li, K., Zheng, H., Dou, Y.-L., Han, L.-Y., & Wang, L. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102361 · Cited by 17
Empfehlungen zur Ernährung von Personen mit Typ-2-Diabetes mellitus
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kronsbein, P., Müssig, K., Pfeiffer, A. F. H., Simon, M., Tombek, A., et al. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1543-1293 · Cited by 11
Benchmarks of Diabetes Care in Men Living With Treated HIV-Infection: A Tertiary Center Experience
Fazekas, M., Tonks, K. T. T., & Samaras, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00634 · Cited by 11
“For patients with isolated hypertriglyceridaemia, omega 3 fatty acid supplementation has been shown to be effective as shown in a meta-analysis including 20 randomized controlled studies (n = 1,209 participants) that demonstrated individuals on supplements had triglyceride levels significantly decreased compared to co…”
BackgroundIto, S., Sano, Y., Nagasawa, K., Matsuura, N., Yamada, Y., Uchinaka, A., Murohara, T., & Nagata, K. (2016) · Obesity Science & Practice · doi:10.1002/osp4.50 · Cited by 9
Polyunsaturated Fatty Acids: Impact on Health and Disease Status
Akbar, S., Bhatti, M. Z., Saeed, R. F., & Qazi, A. S. (2021) · Life and Science · doi:10.37185/lns.1.1.85 · Cited by 9
la Paz, S. M., López, S., Bermúdez, B., Guerrero, J. M., Abia, R., & Muriana, F. J. G. (2017) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8704 · Cited by 9
Li, H., Zhuang, P., Liu, X., Li, Y., Yang, A., Tian, Y., Jia, W. P., Zhang, Y., & Jiao, J. (2025) · Research · doi:10.34133/research.0683 · Cited by 9
“Some other trials even revealed that n-3 PUFA supplementation at a high dose ( > 4.4 g/d) could worsen glucose metabolism [ 9 , 43 ].”
InfluentialKhabir, Z., Abdelhafez, A., Camponovo, F. F., Joyce, P. M., & Garcia‐Bennett, A. E. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2615693 · Cited by 10
“While some studies highlight the advantages of higher EPA:DHA ratios (greater than 1.5) on glucose and lipid control in diabetic patients (Chen et al. 2015), others recommend lower ratios (less than 1.0) for managing inflammation in conditions such as cancer (Szlendak and Kapała 2024).”
InfluentialShort Mediterranean diet screener detects risk of prediabetes in Taiwan, a cross-sectional study
Hou, Y., Li, J.-Y., Chen, J., Hsiao, J., & Wu, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-28573-5 · Cited by 9
Fallah, Z., Vasmehjani, A. A., Aghaei, S., Amiri, M., Raeisi‐Dehkordi, H., Moghtaderi, F., Zimorovat, A., Yazd, E. F., Madadizadeh, F., Khayyatzadeh, S. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78294-6 · Cited by 8
Barham, A., Mohammad, B. A., Hasoun, L., Awwad, S. H., Mosleh, I. M., Aljaberi, A., & Abu‐Samak, M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14779 · Cited by 9
Empfehlungen zur Ernährung von Personen mit Typ-2-Diabetes mellitus
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kronsbein, P., Müssig, K., Nussbaumer, H., Pfeiffer, A. F. H., Simon, M., et al. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01041-4 · Cited by 7
Jan, D. L., Misha, M. S., Destrumelle, S., Terceve, O., Thorin, C., Larcher, T., Ledevin, M., Desfontis, J., Betti, É., & Mallem, Y. (2024) · Biology · doi:10.3390/biology13121070 · Cited by 7
“Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) regulate triglyceride levels [31], reduce inflammation [32], and improve insulin sensitivity [33], primarily through GPR120 and/or PPAR activation [32,34].”
Asbaghi, O., Saboori, S., Falahi, E., Salehpour, S., Rad, E. Y., Abdollahpour, F., & Ojani, Z. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100180 · Cited by 6
Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 2
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kronsbein, P., Müssig, K., Pfeiffer, A. F. H., Simon, M., Tombek, A., et al. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00908-2 · Cited by 6
Abdissa, D. (2021) · Nutrition and Dietary Supplements · doi:10.2147/nds.s298870 · Cited by 6
Mohammed, S. G. A. A., & Qoronfleh, M. W. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_13 · Cited by 6
n-3 Polyunsaturated Fatty Acids in Type 2 Diabetes Mellitus
Valdés‐Ramos, R., López, A. L. G., Martínez‐Carrillo, B. E., & Harbige, L. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813822-9.00013-8 · Cited by 6
Overview of Nutraceuticals and Cardiometabolic Diseases following Socio-Economic Analysis
Bruno, G. M., Dovera, F., Ciccarone, A., & Colombo, G. L. (2022) · Endocrines · doi:10.3390/endocrines3020023 · Cited by 7
Emamat, H., Boushehri, S. N., Eslami, M. A., Totmaj, A. S., & Ghalandari, H. (2022) · Phytotherapy Research · doi:10.1002/ptr.7698 · Cited by 9
Dietary Recommendations for Persons with Type 2 Diabetes Mellitus
Skurk, T., Bosy‐Westphal, A., Grünerbel, A., Kabisch, S., Keuthage, W., Kronsbein, P., Müssig, K., Nussbaumer, H., Pfeiffer, A. F. H., Simon, M., et al. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2166-6772 · Cited by 5
Nam, G. E., Myung, S., & Choi, Y. (2017) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201700111 · Cited by 6
Fish intake and risk of cardiovascular events: an analysis of the VITAL cohort
Caldeira, D., Nogueira-Garcia, B., Abreu, A., & Pinto, F. J. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01244-w · Cited by 5
Orang, Z., Mozaffari–Khosravi, H., Sivandzadeh, G., & Pantović, A. (2019) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-180265 · Cited by 5
Kłosiewicz−Latoszek, L., Cybulska, B., & Tyszko, P. Z. (2020) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/126674 · Cited by 4
“Early studies also suggest a worsening of glucose control, as indicated in the metaanalysis of recent studies and other recent publications [3, 64, 65].”
ResultGeravand, F., Nasli‐Esfahani, E., Montazer, M., Jalalzadeh, M., & Azadbakht, L. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01093-3 · Cited by 4
“…a higher eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) ratio was associated with improved metabolic parameters, including reductions in plasma insulin, hemoglobin A1c (HbA1c), total cholesterol (TC), triglycerides (TG), and body mass index (BMI), which may mitigate the risk of DFUs [15].”
Nutrition and Chronic Conditions
Ojo, O. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-603-5 · Cited by 8
Metadata
- Authors
- Chen, C., Yu, X., & Shao, S.
- Affiliations
- Tongji Hospital (CN)
- Corresponding author
- Shao, Shiying
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-02
- Volume
- 10
- Issue
- 10
- Pages
- e0139565
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4591987
- OpenAlex
- W1827328405
- Cited by
- 133
- References
- 46
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 13 · 2023: 13 · 2022: 14 · 2021: 15 · 2020: 12 · 2019: 19 · 2018: 11 · 2017: 16 · 2016: 6 · 2015: 2
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (81100581)
- Novo Nordisk
- China International Medical Foundation (20110059)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- omega-3 fatty acids, type 2 diabetes, glycemic control, lipid profile, triglycerides, EPA/DHA ratio, HbA1c, fasting blood glucose, postprandial blood glucose, total cholesterol, plasma insulin, body mass index, dietary supplementation
- MeSH terms
- Adolescent, Adult, Blood Glucose, Cholesterol, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Lipids, Male, Middle Aged, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic, Dietary Supplements, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.